Results 211 to 220 of about 42,935 (312)

Changes in Sales of Tobacco and Nicotine Replacement Therapy Products Before and During the COVID-19 Pandemic. [PDF]

Prev Chronic Dis, 2023
Sung J, Shrestha SS, Kim Y, Emery S, Wang X.   +4 more
europepmc   +1 more source

Comparing Motivational Interviewing-Based Treatment and its combination with Nicotine Replacement Therapy on smoking cessation in prisoners: a randomized controlled clinical trial.

, 2015
Farzad Jalali, Reza Afshari, Ali Babaei, Hassan Abasspour, Mohammad Vahedian-Shahroodi   +4 more
openalex   +2 more sources

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 137-150, January 2026.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Tobacco, electronic nicotine delivery system, nicotine replacement therapy, and cannabinoid use during pregnancy: A descriptive cross-sectional survey. [PDF]

PLoS One
Kandhasamy S, Baggio S, Mathis J, Mattmann Y, Maisonneuve E, Auer R, Panchaud A, Jenkinson SP, Schoeni A.   +8 more
europepmc   +1 more source

Awareness and Perception Toward Nicotine Replacement Therapy Among Medical Students at Umm Al-Qura University. [PDF]

Cureus, 2023
Almehmadi S, Almehmadi M, Alhajaji F, Alharbi F, Alqorashi S, Alqahtani M, Alhindi YZ.   +6 more
europepmc   +1 more source

FORMULATION AND OPTIMIZATION OF MUCOADHESIVE BUCCAL FILM FOR NICOTINE REPLACEMENT THERAPY

, 2023
AADITAYA PRAKASH, PRAKASH K. SONI, SURESH K. PASWAN, T. R. Saini   +3 more
openalex   +2 more sources

Real‐world incidence and risk factors of level 3 (severe) hypoglycaemia in adults with type 1 or 2 diabetes (iNPHORM, United States)

Diabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 675-690, January 2026.
Abstract Aims Level 3 (severe) hypoglycaemia is a serious, yet preventable, complication of insulin‐ or secretagogue‐treated diabetes. However, real‐world insight into its incidence and risk factors remains limited. We analysed data from the iNPHORM study to address this gap.
Alexandria Ratzki‐Leewing, Jason E. Black, Jasminder Bhatti, Bridget L. Ryan, Guangyong Zou, Yu Kuei Lin, Shuo J. Huang, Rozalina G. McCoy, Stewart B. Harris   +8 more
wiley   +1 more source

Nicotine replacement therapy as a smoking cessation tool for adolescents: an update. [PDF]

Front Psychiatry
Beis I, Dimou A, Kotoulas SC, Pataka A.
europepmc   +1 more source

Safety of Nicotine Replacement Therapy during Pregnancy: A Narrative Review. [PDF]

Int J Environ Res Public Health, 2022
Morales-Suárez-Varela M, Puig BM, Kaerlev L, Peraita-Costa I, Perales-Marín A.   +4 more
europepmc   +1 more source

Nicotine replacement therapy: Recent advances

, 2013
SG Ferguson
openalex